Download video

Clinical Pharmacy Cases | Join Our Online Clinical Pharmacy Course Today

13 views

Clinical Pharmacy Courses

9 days ago

Clinical Pharmacy Cases | Join Our Online Clinical Pharmacy Course Today

Clinical Pharmacy Cases | Join Our Online Clinical Pharmacy Course Today

New Drug Approvals Inluriyo (imlunestrant), Palsonify (paltusotine), and Rhapsido (remibrutinib)
18:30
New Drug Approvals Inluriyo (imlunestrant), Palsonify (paltusotine), and Rhapsido (remibrutinib)
by Medication Academy
The CLL2-BZAG trial: MRD-guided zanubrutinib, venetoclax, and obinutuzumab in R\/R CLL
1:11
The CLL2-BZAG trial: MRD-guided zanubrutinib, venetoclax, and obinutuzumab in R\/R CLL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Additional research of Donanemab and Lecanemab
1:19
Additional research of Donanemab and Lecanemab
by UCLA Neurology
Top 10 Clinical Pharmacy Skills You Should Master | PART 2 | Clinical Pharmacy Course
33:45
Top 10 Clinical Pharmacy Skills You Should Master | PART 2 | Clinical Pharmacy Course
by Clinical Pharmacy Courses
Real-world efficacy of second-line cabozantinib in renal cell carcinoma
0:40
Real-world efficacy of second-line cabozantinib in renal cell carcinoma
by VJOncology
CPIC guideline for sertraline and CYP2C19, CYP2B6
10:43
CPIC guideline for sertraline and CYP2C19, CYP2B6
by PharmGKB
Q1 Q2 Q3 De-formulation \& Equivalence
5:55
Q1 Q2 Q3 De-formulation \& Equivalence
by Pharma Learning In Depth
CPIC guideline for serotonin reuptake inhibitors and CYP2D6, HTR2A and SLC6A4 - no recommendations
3:34
CPIC guideline for serotonin reuptake inhibitors and CYP2D6, HTR2A and SLC6A4 - no recommendations
by PharmGKB
Two-year results from the COMMODORE 2 trial of crovalimab in complement inhibitor-naïve PNH
1:07
Two-year results from the COMMODORE 2 trial of crovalimab in complement inhibitor-naïve PNH
by VJHemOnc – Video Journal of Hematology \& HemOnc
Can Donanemab Slow Alzheimer's Progression?
6:44
Can Donanemab Slow Alzheimer's Progression?
by Psychopharmacology Institute
Regional Citrate Anticoagulation- Part 2: Citrate \& Calcium Dosing
15:52
Regional Citrate Anticoagulation- Part 2: Citrate \& Calcium Dosing
by Essentials of Acute, Emergency \& Critical Care
Glofitamab monotherapy achieves durable responses in R\/R DLBCL: three-year follow-up of NP30179
5:59
Glofitamab monotherapy achieves durable responses in R\/R DLBCL: three-year follow-up of NP30179
by VJHemOnc – Video Journal of Hematology \& HemOnc
2025 ACCP Annual Meeting Highlights: Hyperthermia \& Artificial Intelligence
55:27
2025 ACCP Annual Meeting Highlights: Hyperthermia \& Artificial Intelligence
by PharmacyToDose
Case #2: Treating a Patient with Stage IV NSCLC with EGFR - 2025 Case Based Panel Discussions
31:07
Case #2: Treating a Patient with Stage IV NSCLC with EGFR - 2025 Case Based Panel Discussions
by Global Resource for Advancing Cancer Education
Inside Clinical Trials: From Lab Bench to Pharmacy Shelf
12:40
Inside Clinical Trials: From Lab Bench to Pharmacy Shelf
by GCP-Mindset - All About Clinical Research
The management of double-refractory CLL: current options and approaches being explored
3:04
The management of double-refractory CLL: current options and approaches being explored
by VJHemOnc – Video Journal of Hematology \& HemOnc
Potency and efficacy of PIP4K2 inhibitors in ALL: looking forward to first-in-human trials
0:52
Potency and efficacy of PIP4K2 inhibitors in ALL: looking forward to first-in-human trials
by VJHemOnc – Video Journal of Hematology \& HemOnc
Chapter 26 CCMA Pharmacology and Medication Administration
1:56:37
Chapter 26 CCMA Pharmacology and Medication Administration
by Nurse Resource Training Center LLC
Clinical Pharmacy Explained: Roles, Skills, and Career Opportunities in 2025
26:09
Clinical Pharmacy Explained: Roles, Skills, and Career Opportunities in 2025
by Clinical Pharmacy Courses
Interim results from a Phase II trial of epcoritamab plus lenalidomide in treatment-naive FL
1:42
Interim results from a Phase II trial of epcoritamab plus lenalidomide in treatment-naive FL
by VJHemOnc – Video Journal of Hematology \& HemOnc
CPIC guideline for venlafaxine and CYP2D6
6:30
CPIC guideline for venlafaxine and CYP2D6
by PharmGKB
Daily Rounds: Bioequivalence of Compounded Extended-Release Levetiracetam
1:01
Daily Rounds: Bioequivalence of Compounded Extended-Release Levetiracetam
by Clinician's Brief
Medicus Pharma advances Phase 2 clinical study, eyes FDA fast-track approval
5:08
Medicus Pharma advances Phase 2 clinical study, eyes FDA fast-track approval
by Proactive Investors